相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
Bruce N. Cronstein et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis
Pnina Fishman et al.
CLINICAL RHEUMATOLOGY (2016)
Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis A Systematic Review and a Network Meta-Analysis
Chao Chen et al.
MEDICINE (2016)
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis
Fabrizio Cantini et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
Pier Andrea Borea et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Signaling via the NFκB system
Simon Mitchell et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)
Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review
Celia Maria Quinonez-Flores et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Adenosine: an endogenous mediator in the pathogenesis of psoriasis
Moira Festugato
ANAIS BRASILEIROS DE DERMATOLOGIA (2015)
New immune cells in spondyloarthritis: Key players or innocent bystanders?
Koen Venken et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2015)
Serum matrix metalloproteinases-3 levels in patients with ankylosing spondylitis
J. W. Gao et al.
GENETICS AND MOLECULAR RESEARCH (2015)
History and Perspectives of A2A Adenosine Receptor Antagonists as Potential Therapeutic Agents
Delia Preti et al.
MEDICINAL RESEARCH REVIEWS (2015)
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Ae R. Noort et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Making the next steps in psoriatic arthritis management: current status and future directions
Diviya Sritheran et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2015)
Ankylosing spondylitis: A state of the art factual backbone
Mohammad Ghasemi-rad et al.
WORLD JOURNAL OF RADIOLOGY (2015)
The A3 Adenosine Receptor: History and Perspectives
Pier Andrea Borea et al.
PHARMACOLOGICAL REVIEWS (2015)
The interleukin-23/interleukin-17 immune axis as a promising new target in the treatment of spondyloarthritis
Nataliya Yeremenko et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis
Kenia Rodrigues de Andrade et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis
Carolyn M. Dancevic et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Activation of adenosine A2A receptor reduces osteoclast formation via PKA- and ERK1/2-mediated suppression of NFκB nuclear translocation
Aranzazu Mediero et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated
Fabrizio Vincenzi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Serological markers in psoriatic arthritis: promising tools
Roberta Ramonda et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
A2A Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats
Fabrizio Vincenzi et al.
PLOS ONE (2013)
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
Peter Schafer
BIOCHEMICAL PHARMACOLOGY (2012)
Pharmacological and therapeutic effects of A3 adenosine receptor agonists
Pnina Fishman et al.
DRUG DISCOVERY TODAY (2012)
Adenosine receptors and cancer
Stefania Gessi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)
CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation
Daniela Impellizzeri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Adenosine receptor targeting in health and disease
Stefania Gessi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
CGS 21680, an Agonist of the Adenosine (A2A) Receptor, Reduces Progression of Murine Type II Collagen-induced Arthritis
Emanuela Mazzon et al.
JOURNAL OF RHEUMATOLOGY (2011)
A(2A) and A(3) adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release
Katia Varani et al.
ARTHRITIS RESEARCH & THERAPY (2011)
The role of adenosine receptors in rheumatoid arthritis
Katia Varani et al.
AUTOIMMUNITY REVIEWS (2010)
A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson's disease
Katia Varani et al.
FASEB JOURNAL (2010)
Immunologic rheumatic disorders
Amy Joseph et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Normalization of A2A and A3 Adenosine Receptor Up-Regulation in Rheumatoid Arthritis Patients by Treatment With Anti-Tumor Necrosis Factor α but Not Methotrexate
Katia Varani et al.
ARTHRITIS AND RHEUMATISM (2009)
The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease
A. Ochaion et al.
CELLULAR IMMUNOLOGY (2009)
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats
A. Ochaion et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Adenosine receptors:: therapeutic aspects for inflammatory and immune diseases
Gyorgy Hasko et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Classification criteria for psoriatic arthritis - Development of new criteria from a large international study
William Taylor et al.
ARTHRITIS AND RHEUMATISM (2006)
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease
K Varani et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Modulation of orphan nuclear receptor NURR1 expression by methotrexate in human inflammatory joint disease involves adenosine A2A receptor-mediated responses
JA Ralph et al.
JOURNAL OF IMMUNOLOGY (2005)
分享论文
